Stem cell transplants show 60% progression-free survival at 10 years for severe systemic sclerosis
An international study reports 60% progression-free survival at 10 years after autologous bone marrow transplantation in patients treated for early severe systemic sclerosis, providing evidence of sustained positive clinical outcomes and long-term safety for the rare autoimmune disease.
